Marrone Bio Innovations

Marrone Bio Innovations Short-term Debt

Delisted

The Short-Term Debt of Marrone Bio Innovations (MBII) as of Nov 18, 2026 is 27.29 M USD. In the previous year, Short-Term Debt was 1.01 M USD — a change of 2,607.34% (higher).

Short-term Debt

27.29 MUSD

YoY

2,607.34%

Last updated:

Short-Term Debt of Marrone Bio Innovations is 2021 27.29 M USD. Short-Term Debt of Marrone Bio Innovations was 2020 1.01 M USD. It decreases by 2,607.34% higher compared to the previous year.

The Marrone Bio Innovations Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2014
12.64 M USD
Jan 1, 2015
12.64 M USD
Jan 1, 2016
252,000.00 USD
Jan 1, 2017
1.52 M USD
Jan 1, 2018
2.32 M USD
Jan 1, 2019
3.90 M USD
Jan 1, 2020
1.01 M USD
Jan 1, 2021
27.29 M USD
The Marrone Bio Innovations Short-term Debt history
YEARShort-term DebtYoY
27.29 MUSD+2,607.34%
1.01 MUSD-74.15%
3.90 MUSD+68.21%
2.32 MUSD+52.10%
1.52 MUSD+504.76%
252,000.00USD-98.01%
12.64 MUSD0.00%
12.64 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

Short-Term Debt of Marrone Bio Innovations is 27.29 M USD in 2021.

Short-Term Debt of Marrone Bio Innovations changed from 1.01 M USD to 27.29 M USD, representing a 2,607.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Marrone Bio Innovations since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Marrone Bio Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations